Evaxion to present EVX-01 cancer vaccine immune data at SITC 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. KNX
10. ELV

Go back to Evaxion to present EVX-01 cancer vaccine immune data at SITC 2026

Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting

October 2, 2026 9:00 AM EDT

New immune data from the phase 2 trial with EVX-01 to be presented both in an oral and poster presentationNew data follows from the three-year clinical update for EVX-01 to be provided at the European Society for Medical Oncology (ESMO) 2026 congress on October 24, 2026

COPENHAGEN, Denmark, October 2, 2026 - Evaxion A/S (NASDAQ: EVAX) (Evaxion), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology platform, will present new immune data for AI-designed personalized cancer vaccine EVX-01 at the Society for Immunotherapy of... More